Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?

Savioli, Felicio; Rocha, Leonardo; Góis, Aécio; Nakano, Luis Carlos

Savioli, Felicio; Rocha, Leonardo; Góis, Aécio; Nakano, Luis Carlos.

J Trauma Acute Care Surg ; 89(6): e187-e188, 2020 12.

Article in English | MEDLINE | ID: covidwho-941590

Subject(s)

Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Respiratory Distress Syndrome/virology; Thrombolytic Therapy; Tissue Plasminogen Activator/administration & dosage; Betacoronavirus; COVID-19; Coronavirus Infections/blood; Humans; Pandemics; Pneumonia, Viral/blood; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Distress Syndrome / Thrombolytic Therapy / Tissue Plasminogen Activator / Coronavirus Infections Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Trauma Acute Care Surg Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google